Immunology is the systematic evaluation of the means through which human beings protect themselves and respond to the attack of internal and external agents, and Edward Jenner and Louis Pasteur (1822-1895) are considered pioneers ofthis field. Jenner observed the protective effect of cowpox against smallpox and inoculated the cowpox in human beings to protect them from the often lethal smallpox. Pasteur developed in his laboratory a vaccine against rabies and elaborated methods for attenuating the virulence of pathogenic microorganisms while maintaining their immunogenicity. Pharmacology is the area of medical science dealing with drugs and their uses, and it was during the nineteenth century that it assumed its status of scientific specialty, mainly in German-speaking Europe, through the establishment of pharmacological institutes and dedicated laboratories. The discovery and the synthesis of drugs and the systematic evaluation of their activity have constituted through time a scientific field in which immunology and pharmacology have met and given origin to notable progress in the history of science. The development of chemotherapy, as well as of organ and tissue transplantation, in the twentieth century has been decisively promoted by both immunology and pharmacology. In the last three decades the relationship between these two scientific branches has become increasingly closer in basic research, clinical science, medical education and also editorial scientific activity, as documented by the Journal hosting this paper.
According to the "Oxford English Dictionary" (1) the word "immunology", in its meaning of "The study of the phenomena of immunity ... ; the branch of science concerned with the structure and function of the immune system" is attested in the English language for the first time in 1909, in the February 12 issue of Science (2) . The Latin term "immunis", composing the word, stood for "exempt, free", and immunology is today considered the systematic evaluation of the means through which living organisms protect themselves and respond to the attack of internal and external agents.
At the end of the eighteenth century the British surgeon Edward Jenner (1749-1823) systematically observed the "preventive" effect of cowpox against smallpox and translated his knowledge into systematic practice, inoculating cowpox in human beings so as to protect them from the dangerous and often lethal smallpox (3) . Another milestone in the evolution of immunology is linked to the many studies of the French chemist Louis Pasteur (1822-1895) on chicken cholera and on the anthrax bacillus during the second half of the nineteenth century (4). Pasteur developed in his laboratory a vaccine against rabies and elaborated methods for attenuating the virulence of pathogenic microorganisms while maintaining their immunogenicity. The term "pharmacology", in its meaning of "The branch of medical science that deals with drugs and their uses", is first attested in English in 1704 (1). It is interesting to note that with the word "pharmacon" the ancient Greeks indicated every substance able to modify the human body, and therefore both poisons and drugs. Between the IV and the III centuries BC, the great Theophrastus, a polymath who studied physics and metaphysics, also investigated biology and botanic. His works "Enquiry into Plants" and "Growth of Plants" were paramount reference texts in the classical world and exerted a relevant action on the botanical knowledge and pharmacopeia of the Middle Ages (5) (6) . It was during the nineteenth century, however, that pharmacology assumed its status of scientific specialty, mainly in Germanspeaking Europe, through the establishment of pharmacological institutes and dedicated laboratories.
The discovery and the synthesis of drugs and the systematic evaluation of their activity have constituted through time a scientific area in which immunology and pharmacology have met and given origin to notable progress in the history of science. At the end of the nineteenth century major results in this common field were obtained by the German bacteriologist Emil Behring (1854-1917), Nobel Prize in Physiology or Medicine in 1901, who demonstrated the possibility of equipping animals with passive immunity against tetanus if they were injected with the blood serum of other animals infected with tetanus itself (7) . Behring elaborated and introduced the diphtheria antitoxin in clinical medicine. The German scientist Paul Ehrlich (1854-1915), Nobel Prize in 1908, besides investigating the diphtheria toxin, explored the quantitative methods for measuring toxins and elaborated the idea of the one-dose treatment for various infections (8) . At the beginning of the twentieth century Ehrlich also identified pharmacological agents for the therapy of syphilis and trypanosomiasis. Ehrlich was convinced that chemical substances could and should be implemented both in the healing process of damaged cells and sick organisms, and in the elimination of infectious agents as well. This scientist may be considered the nineteenth century link between immunology and pharmacology, and he paved the way for the great acceleration in their evolution that occurred in the twentieth century. In the nineteen hundreds many Nobel Prizes were attributed to scientists researching precisely in these branches of medicine.
More recently, the development of chemotherapy (whose founder is considered by many science historians to be Paul Ehrlich himself), as well as the development of organ and tissue transplantation has been decisively promoted by both immunology and pharmacology (9) . Paradigmatic is the clinical use of cyclosporine, the first effective immunosuppressive drug in the prevention and treatment of transplant rejection introduced in the late seventies, and which concentrates within itself multiple knowledge achievements in the shared fields of immunology and pharmacology.
In the last three decades the relationship between immunology and pharmacology has become increasingly closer in basic research, clinical science, medical education and also editorial scientific activity, as documented by the Journal hosting this paper (10) . Various other examples, besides that of cyclosporine, may be cited in recent years, and these contributions collocate themselves in an Evidence-Based History of Medicine perspective, with their relevant fall out on the understanding of specific diseases, the general improvement in health care and the integrated promotion of life quality and human health.
